Robert T Jacobs

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 5

Top Venues

ACS infectious diseases

Journal of medicinal chemistry

Nature microbiology

Medicines for Malaria Venture

Cornell University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medicines for Malaria Venture Oct 22 2018

Switzerland

Visiting Senior Director of Medicinal Chemistry

Education History

Cornell University Sep 01 1981 - Aug 31 1985

United States

PHD :: Chemistry

Publications

Angel M Padilla, Wei Wang, Tsutomu Akama, David S Carter, Eric Easom, Yvonne R Freund, Jason S Halladay, Yang Liu, Sarah A Hamer, Carolyn L Hodo, Gregory K Wilkerson, Dylan Orr, Brooke White, Arlene J George, Huifeng Shen, Yiru Jin, Michael Zhuo Wang, Susanna Tse, Robert T Jacobs, Rick L Tarleton
Discovery of an orally active benzoxaborole prodrug effective in the treatment of Chagas disease in non-human primates. Nature microbiology 7 (10) (2022)
Charles E Mowbray, Stéphanie Braillard, Paul A Glossop, Gavin A Whitlock, Robert T Jacobs, Jason Speake, Bharathi Pandi, Bakela Nare, Louis Maes, Vanessa Yardley, Yvonne Freund, Richard J Wall, Sandra Carvalho, Davide Bello, Magali Van den Kerkhof, Guy Caljon, Ian H Gilbert, Victoriano Corpas-Lopez, Iva Lukac, Stephen Patterson, Fabio Zuccotto, Susan Wyllie
DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral Leishmaniasis. Journal of medicinal chemistry 64 (21) (2021)
David S Carter, Robert T Jacobs, Yvonne R Freund, Pamela W Berry, Tsutomu Akama, Eric E Easom, Christopher S Lunde, Fernando Rock, Rianna Stefanakis, James McKerrow, Chelsea Fischer, Christina A Bulman, Kee Chong Lim, Brian M Suzuki, Nancy Tricoche, Judy A Sakanari, Sara Lustigman, Jacob J Plattner
Macrofilaricidal Benzimidazole-Benzoxaborole Hybrids as an Approach to the Treatment of River Blindness: Part 2. Ketone Linked Analogs. ACS infectious diseases 6 (2) (2020)
Tsutomu Akama, Yvonne R Freund, Pamela W Berry, David S Carter, Eric E Easom, Kurt Jarnagin, Christopher S Lunde, Jacob J Plattner, Fernando Rock, Rianna Stefanakis, Chelsea Fischer, Christina A Bulman, Kee Chong Lim, Brian M Suzuki, Nancy Tricoche, Abdelmoneim Mansour, Utami DiCosty, Scott McCall, Ben Carson, John W McCall, James McKerrow, Marc P Hübner, Sabine Specht, Achim Hoerauf, Sara Lustigman, Judy A Sakanari, Robert T Jacobs
Macrofilaricidal Benzimidazole-Benzoxaborole Hybrids as an Approach to the Treatment of River Blindness: Part 1. Amide Linked Analogs. ACS infectious diseases 6 (2) (2020)
Robert T Jacobs, Christopher S Lunde, Yvonne R Freund, Vincent Hernandez, Xianfeng Li, Yi Xia, David S Carter, Pamela W Berry, Jason Halladay, Fernando Rock, Rianna Stefanakis, Eric Easom, Jacob J Plattner, Louise Ford, Kelly L Johnston, Darren A N Cook, Rachel Clare, Andrew Cassidy, Laura Myhill, Hayley Tyrer, Joanne Gamble, Ana F Guimaraes, Andrew Steven, Franziska Lenz, Alexandra Ehrens, Stefan J Frohberger, Marianne Koschel, Achim Hoerauf, Marc P Hübner, Case W McNamara, Malina A Bakowski, Joseph D Turner, Mark J Taylor, Stephen A Ward
Boron-Pleuromutilins as Anti- Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic Filariasis. Journal of medicinal chemistry 62 (5) (2019)

Robert T Jacobs.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Robert T Jacobs